IdentificationGeneric Name(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACIDDrugBank Accession NumberDB07409BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID (DB07409)× CloseWeightAverage: 434.3161 Monoisotopic: 434.068426018 Chemical FormulaC20H20O7P2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUDitrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)Not AvailableEscherichia coli (strain K12)AbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as p-terphenyls. These are terphenyls with a structure containing the 1,4-diphenylbenzene skeleton.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassTerphenylsDirect ParentP-terphenylsAlternative ParentsBiphenyls and derivatives / Bisphosphonates / Organic phosphonic acids / Organopnictogen compounds / Organophosphorus compounds / Organooxygen compounds / Organic oxides / Hydrocarbon derivativesSubstituentsAromatic homomonocyclic compound / Biphenyl / Bisphosphonate / Hydrocarbon derivative / Organic oxide / Organic oxygen compound / Organooxygen compound / Organophosphonic acid / Organophosphonic acid derivative / Organophosphorus compoundMolecular FrameworkAromatic homomonocyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyMPBUFKZCEBTBSK-UHFFFAOYSA-NInChIInChI=1S/C20H20O7P2/c21-20(28(22,23)24,29(25,26)27)14-15-5-4-8-19(13-15)18-11-9-17(10-12-18)16-6-2-1-3-7-16/h1-13,21H,14H2,(H2,22,23,24)(H2,25,26,27)IUPAC Name(1-hydroxy-2-{4'-phenyl-[1,1'-biphenyl]-3-yl}-1-phosphonoethyl)phosphonic acidSMILESOC(CC1=CC=CC(=C1)C1=CC=C(C=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=OReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound16122554PubChem Substance99443880ChemSpider17279473BindingDB25266ChEMBLCHEMBL262616PDBe LigandB28PDB Entries2e9aClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.104 mg/mLALOGPSlogP1.84ALOGPSlogP2.75ChemaxonlogS-3.6ALOGPSpKa (Strongest Acidic)0.69ChemaxonpKa (Strongest Basic)-5.2ChemaxonPhysiological Charge-3ChemaxonHydrogen Acceptor Count7ChemaxonHydrogen Donor Count5ChemaxonPolar Surface Area135.29 Å2ChemaxonRotatable Bond Count6ChemaxonRefractivity109.55 m3·mol-1ChemaxonPolarizability41.53 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption-0.5924Blood Brain Barrier+0.8783Caco-2 permeable-0.7143P-glycoprotein substrateNon-substrate0.6395P-glycoprotein inhibitor INon-inhibitor0.8726P-glycoprotein inhibitor IINon-inhibitor0.9822Renal organic cation transporterNon-inhibitor0.9545CYP450 2C9 substrateNon-substrate0.7729CYP450 2D6 substrateNon-substrate0.8351CYP450 3A4 substrateNon-substrate0.6821CYP450 1A2 substrateNon-inhibitor0.8926CYP450 2C9 inhibitorNon-inhibitor0.8535CYP450 2D6 inhibitorNon-inhibitor0.9165CYP450 2C19 inhibitorNon-inhibitor0.8931CYP450 3A4 inhibitorNon-inhibitor0.9419CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9468Ames testNon AMES toxic0.8119CarcinogenicityNon-carcinogens0.6673BiodegradationNot ready biodegradable0.9258Rat acute toxicity2.0901 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9524hERG inhibition (predictor II)Non-inhibitor0.8467  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)KindProteinOrganismEscherichia coli (strain K12)Pharmacological actionUnknownGeneral FunctionMagnesium ion bindingSpecific FunctionGenerates ditrans,octacis-undecaprenyl pyrophosphate (UPP) from isopentenyl pyrophosphate (IPP) and farnesyl diphosphate (FPP). UPP is the precursor of glycosyl carrier lipid in the biosynthesis of...Gene NameispUUniprot IDP60472Uniprot NameDitrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)Molecular Weight28443.92 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:21 / Updated at June 12, 2020 16:52 